PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VU4WTD8

Delayed Deutsche Boerse AG 12:44:53 27/05/2024 BST
15.2 EUR 0.00% Intraday chart for PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE
Current month-3.86%
1 month-7.03%
Date Price Change
27/05/24 15.2 0.00%
24/05/24 15.2 -4.94%
23/05/24 15.99 +3.09%
22/05/24 15.51 +6.45%
21/05/24 14.57 +6.20%

Delayed Quote Deutsche Boerse AG

Last update May 27, 2024 at 12:44 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU4WTD
ISINDE000VU4WTD8
Date issued 16/03/2023
Strike 54.07
Maturity Unlimited
Parity 1 : 1
Emission price 20.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 24.15
Lowest since issue 5.74
Spread 0.08
Spread %0.52%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.16%
Consensus